OpenAlex
PricingAboutJobs
Log inGet started
Work

Metabolic reprogramming and drug resistance in hepatocellular carcinoma: The emerging role of SREBP2-driven cholesterol metabolism

HTML

Year: 2026
Type: review
Source: Drug Discovery Today
DOI: 10.1016/j.drudis.2026.104788
Authors: Veerababu Nagati, Swathi Tenugu, Miguel Salazar, Manish K. Tripathi
Institutions: The University of Texas Rio Grande Valley, Clemson University
Language: English

Topic: Cancer, Lipids, and Metabolism
Subfield: Cancer Research
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: hepatocellular carcinoma, drug resistance, metabolic reprogramming, SREBP2, cholesterol metabolism, cholesterol biosynthesis, multikinase inhibitor, receptor tyrosine kinase, lipid rafts, ABCA1, cholesterol efflux, YB-1, PI3K/Akt signaling, lipid metabolism
SDG: Good health and well-being

Open Access status: green

Funders: Alzheimer's Association, Cancer Prevention and Research Institute of Texas, University of Texas Rio Grande Valley, National Institutes of Health, National Institute of General Medical Sciences
Awards: G2897265798, LncRNA Malat1 as a potential therapeutic target for Alzheimer’s Disease, Role of lncRNA UCA1 in anoikis resistantce and colorectal cancer metastasis
OpenAlex ID: W7204451618
FWCI: 0.521
Cites: 137
Cited by: 1
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms